Development, Implementation and Evaluation of a Complex Regional Intervention for Type 2 Diabetes.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes Type 2
- Sponsor
- Universiteit Antwerpen
- Enrollment
- 375
- Primary Endpoint
- HBA1C
- Last Updated
- 17 years ago
Overview
Brief Summary
The purpose of this study is to determine whether regional implementation of shared care with respect to type 2 diabetes is feasible, effective and cost-effective.
Detailed Description
Background Diabetes is an important chronic condition with significant associated morbidity and mortality, which can be reduced by effective care. An interdisciplinary approach, sharing responsibility and involvement and education of patients are of major importance in diabetes care. In Belgium a research project aimed at creating regional diabetes shared care was set up. Research questions * Is regional implementation of shared care feasible? * Does it increases quality of care (evidence based care) and patient satisfaction with care? * Does it have a positive effect on health status (emotional distress, overall quality of life, Hba1c)? Methods Controlled trial (July 2004 - June 2006) with a regional complex intervention comprising introduction of a care-manager and 2 community based diabetes educators, development and implementation of a shared care protocol (with a central role for the GP), regional feedback on the quality of diabetes care and patient education. Practitioners and patients participate on a voluntary basis. In the control region usual care continues. Biophysical, psychosocial and process outcomes were collected thru GP registration of patients records and self-administered patient questionnaires (PAID, QUOTE).
Investigators
Eligibility Criteria
Inclusion Criteria
- •All type 2 diabetes patients living in the defined intervention region
- •All caregivers involved in type 2 diabetes care in the defined intervention region
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
HBA1C
Time Frame: Longitudinal analysis on measurements from 01/01/2004 until 31/12/2006
Secondary Outcomes
- Total Cholesterol(Longitudinal analysis on measurements from 01/01/2004 until 31/12/2006)
- LDL-C(Longitudinal analysis on measurements from 01/01/2004 until 31/12/2006)
- HDL-C(Longitudinal analysis on measurements from 01/01/2004 until 31/12/2006)
- microalb.(Longitudinal analysis on measurements from 01/01/2004 until 31/12/2006)
- blood creatinine(Longitudinal analysis on measurements from 01/01/2004 until 31/12/2006)
- ophthalmist consults(Longitudinal analysis on measurements from 01/01/2004 until 31/12/2006)
- Statine prescriptions(Longitudinal analysis on measurements from 01/01/2004 until 31/12/2006)
- Influenza Vaccination Prescriptions(Longitudinal analysis on measurements from 01/01/2004 until 31/12/2006)